Novo Integrated Sciences Inc (NVOS) - News Archive

Novo Integrated Sciences Receives SBLC Confirmation from HSBC and Increases Stock Repurchase Program; Acenzia Selected for Protein Industries Canada ProgramNovo Integrated Sciences, Inc. (NASDAQ: NVOS), a leading global...

Novo Integrated Sciences Secures Key Financing and Strategic Partnership for Innovation in Plant-Based Proteins BELLEVUE, Wash. Novo Integrated Sciences, Inc. (NASDAQ: NVOS), a prominent player in the integrated healthc...

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) has recently made a strategic move to increase its maximum stock repurchase program from $5 million to $10 million. This decision by the company s Board of Directors reflect...

Novo Integrated Sciences, Inc. recently announced its Canadian subsidiary, Acenzia Inc., has been chosen to participate in a groundbreaking project initiated by Protein Industries Canada. This collaboration aims to deve...

Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant-Based Protein ProductsBELLEVUE, Wash. - Novo Integrated Sciences, Inc. (NASDAQ: NVOS) announced today that its subsidiary, Acenzia In...

Novo Integrated Sciences, a healthcare technology company based in Bellevue, Washington, has recently made a significant change to its financial agreement with RC Consulting Consortium Group. The $70,000,000 promissory...

Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory NoteNovo Integrated Sciences, Inc. (NASDAQ: NVOS) has recently announced that the Company and RC Consulting Consortium Group LLC (...